Legis Daily

SAFE Act

USA118th CongressHR-568| House 
| Updated: 2/3/2023
Chris Pappas

Chris Pappas

Democratic Representative

New Hampshire

Cosponsors (19)
Marie Gluesenkamp Perez (Democratic)Abigail Davis Spanberger (Democratic)Jennifer L. McClellan (Democratic)Derek Kilmer (Democratic)Angie Craig (Democratic)Donald G. Davis (Democratic)Daniel T. Kildee (Democratic)Maria Elvira Salazar (Republican)Dan Newhouse (Republican)Nikki Budzinski (Democratic)Ami Bera (Democratic)Josh Harder (Democratic)Betty McCollum (Democratic)Sharice Davids (Democratic)Tony Gonzales (Republican)Seth Magaziner (Democratic)Michael Lawler (Republican)Jason Crow (Democratic)Mike Levin (Democratic)

Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Save Americans from the Fentanyl Emergency Act or the SAFE Act This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on December 31, 2024. It limits the application of mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows a federal court to vacate or reduce the sentence for convictions of offenses involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II. The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-2748
SAFE Act

Bill from Previous Congress

HR 116-6498
SAFE Act of 2020

Bill from Previous Congress

HR 116-1468
SAFE Act of 2019

Bill from Previous Congress

HR 117-2872
SAFE Act

Bill from Previous Congress

HR 117-6946
SAFE Act of 2022

Bill from Previous Congress

HR 117-3355
SAFE Act of 2021

Bill from Previous Congress

HR 115-3317
SAFE Act of 2017
Jan 26, 2023
Introduced in House
Jan 26, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 1, 2023
Sponsor introductory remarks on measure. (CR H588)
Feb 3, 2023
Referred to the Subcommittee on Health.
Jul 23, 2024

Latest Companion Bill Action

S 118-4752
Introduced in Senate
  • Bill from Previous Congress

    HR 116-2748
    SAFE Act


  • Bill from Previous Congress

    HR 116-6498
    SAFE Act of 2020


  • Bill from Previous Congress

    HR 116-1468
    SAFE Act of 2019


  • Bill from Previous Congress

    HR 117-2872
    SAFE Act


  • Bill from Previous Congress

    HR 117-6946
    SAFE Act of 2022


  • Bill from Previous Congress

    HR 117-3355
    SAFE Act of 2021


  • Bill from Previous Congress

    HR 115-3317
    SAFE Act of 2017


  • January 26, 2023
    Introduced in House


  • January 26, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • February 1, 2023
    Sponsor introductory remarks on measure. (CR H588)


  • February 3, 2023
    Referred to the Subcommittee on Health.


  • July 23, 2024

    Latest Companion Bill Action

    S 118-4752
    Introduced in Senate

Crime and Law Enforcement

Related Bills

  • HR 118-1580: CEASE Overdose Act of 2023
  • S 118-600: Stopping Overdoses of Fentanyl Analogues Act
  • HR 118-467: HALT Fentanyl Act
  • HR 118-3629: Federal Initiative to Guarantee Health by Targeting Fentanyl Act
  • S 118-1141: HALT Fentanyl Act
  • HR 118-171: HALT Fentanyl Act
Administrative law and regulatory proceduresCongressional oversightCriminal procedure and sentencingDepartment of JusticeDrug trafficking and controlled substancesGovernment studies and investigationsInternational law and treatiesLicensing and registrationsManufacturingResearch administration and funding

SAFE Act

USA118th CongressHR-568| House 
| Updated: 2/3/2023
Save Americans from the Fentanyl Emergency Act or the SAFE Act This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on December 31, 2024. It limits the application of mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows a federal court to vacate or reduce the sentence for convictions of offenses involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II. The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-2748
SAFE Act

Bill from Previous Congress

HR 116-6498
SAFE Act of 2020

Bill from Previous Congress

HR 116-1468
SAFE Act of 2019

Bill from Previous Congress

HR 117-2872
SAFE Act

Bill from Previous Congress

HR 117-6946
SAFE Act of 2022

Bill from Previous Congress

HR 117-3355
SAFE Act of 2021

Bill from Previous Congress

HR 115-3317
SAFE Act of 2017
Jan 26, 2023
Introduced in House
Jan 26, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 1, 2023
Sponsor introductory remarks on measure. (CR H588)
Feb 3, 2023
Referred to the Subcommittee on Health.
Jul 23, 2024

Latest Companion Bill Action

S 118-4752
Introduced in Senate
  • Bill from Previous Congress

    HR 116-2748
    SAFE Act


  • Bill from Previous Congress

    HR 116-6498
    SAFE Act of 2020


  • Bill from Previous Congress

    HR 116-1468
    SAFE Act of 2019


  • Bill from Previous Congress

    HR 117-2872
    SAFE Act


  • Bill from Previous Congress

    HR 117-6946
    SAFE Act of 2022


  • Bill from Previous Congress

    HR 117-3355
    SAFE Act of 2021


  • Bill from Previous Congress

    HR 115-3317
    SAFE Act of 2017


  • January 26, 2023
    Introduced in House


  • January 26, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • February 1, 2023
    Sponsor introductory remarks on measure. (CR H588)


  • February 3, 2023
    Referred to the Subcommittee on Health.


  • July 23, 2024

    Latest Companion Bill Action

    S 118-4752
    Introduced in Senate
Chris Pappas

Chris Pappas

Democratic Representative

New Hampshire

Cosponsors (19)
Marie Gluesenkamp Perez (Democratic)Abigail Davis Spanberger (Democratic)Jennifer L. McClellan (Democratic)Derek Kilmer (Democratic)Angie Craig (Democratic)Donald G. Davis (Democratic)Daniel T. Kildee (Democratic)Maria Elvira Salazar (Republican)Dan Newhouse (Republican)Nikki Budzinski (Democratic)Ami Bera (Democratic)Josh Harder (Democratic)Betty McCollum (Democratic)Sharice Davids (Democratic)Tony Gonzales (Republican)Seth Magaziner (Democratic)Michael Lawler (Republican)Jason Crow (Democratic)Mike Levin (Democratic)

Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

Crime and Law Enforcement

Related Bills

  • HR 118-1580: CEASE Overdose Act of 2023
  • S 118-600: Stopping Overdoses of Fentanyl Analogues Act
  • HR 118-467: HALT Fentanyl Act
  • HR 118-3629: Federal Initiative to Guarantee Health by Targeting Fentanyl Act
  • S 118-1141: HALT Fentanyl Act
  • HR 118-171: HALT Fentanyl Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresCongressional oversightCriminal procedure and sentencingDepartment of JusticeDrug trafficking and controlled substancesGovernment studies and investigationsInternational law and treatiesLicensing and registrationsManufacturingResearch administration and funding